Randomized phase III trial of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages (T2N0, T1 - 2N1, T3N0 and T3N1) non-small cell lung cancer (NSCLC)

Trial Profile

Randomized phase III trial of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages (T2N0, T1 - 2N1, T3N0 and T3N1) non-small cell lung cancer (NSCLC)

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Cisplatin; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms ChEST
  • Most Recent Events

    • 23 Jun 2008 Status change
    • 30 May 2008 Results reported at ASCO 2008.
    • 27 Dec 2007 The expected completion date for this trial is now 1 Jun 2015 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top